P

Inventor

SMITH ERIC

US187 patents
⚠️ This page may combine multiple inventors who share the name “SMITH ERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

20 patents
US9657102B2May 23, 2017

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

REGENERON PHARMA125 citations99
US8043617B2Oct 25, 2011

Human antibodies to human IL-6 receptor

REGENERON PHARMA91 citations99
US7582298B2Sep 1, 2009

High affinity antibodies to human IL-6 receptor

REGENERON PHARMA390 citations99
US10772972B2Sep 15, 2020

Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof

REGENERON PHARMA44 citations97
US10738130B2Aug 11, 2020

Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof

REGENERON PHARMA50 citations97
US9359437B2Jun 7, 2016

Antibodies comprising chimeric constant domains

REGENERON PHARMA91 citations97
US7534868B1May 19, 2009

Human antibodies to human delta like ligand 4

REGENERON PHARMA38 citations96
US7488806B2Feb 10, 2009

Human antibodies to human delta like ligand 4

REGENERON PHARMA41 citations96
US10179819B2Jan 15, 2019

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

REGENERON PHARMA25 citations93
US11384153B2Jul 12, 2022

Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof

REGENERON PHARMA16 citations92
US9884916B2Feb 6, 2018

High affinity antibodies to human IL-6 receptor

REGENERON PHARMA13 citations92
US7919593B2Apr 5, 2011

Human antibodies to human delta like ligand 4

REGENERON PHARMA25 citations92
US8048418B2Nov 1, 2011

Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists

REGENERON PHARMA34 citations90
US11518807B2Dec 6, 2022

Heavy chain constant regions with reduced binding to Fc gamma receptors

REGENERON PHARMA8 citations86
US10556952B2Feb 11, 2020

Heavy chain constant regions with reduced binding to Fc gamma receptors

REGENERON PHARMA12 citations86
US11155633B2Oct 26, 2021

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

REGENERON PHARMA9 citations85
US10988537B2Apr 27, 2021

Antibodies comprising chimeric constant domains

REGENERON PHARMA10 citations85
US11725034B2Aug 15, 2023

IL2 agonists and methods of use thereof

REGENERON PHARMA4 citations84
US11548947B2Jan 10, 2023

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

REGENERON PHARMA10 citations84
US11453721B2Sep 27, 2022

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

REGENERON PHARMA10 citations84

WESTINGHOUSE AIR BRAKE CO

4 patents

USAA

3 patents

RADIN ALLEN

3 patents

UNITED SERVICES AUTOMOBILE ASS (USAA)

2 patents

MICROSOFT CORP

2 patents

DAVIS SAMUEL

1 patent

INFINITEKEY INC

1 patent

IROBOT CORP

1 patent

SPINDANCE INC

1 patent

DENSO CORP

1 patent

ETHICON ENDO SURGERY INC

1 patent

SMITH ERIC

1 patent

STEVENS SEAN

1 patent

DEPUY SPINE INC

1 patent

CIRRUS LOGIC INC

1 patent

BORDEN INC

1 patent

DEPUY ACROMED INC

1 patent

DENSO INT AMERICA INC

1 patent

VULCAN INC

1 patent

BROOKS BENJAMIN

1 patent

TOYOTA ENG & MFG NORTH AMERICA

1 patent

Showing the top 50 of 187 patents by PatentIndex Score.